Dose-volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer.
Lukasz KuncmanKonrad StawiskiMichał MasłowskiJakub KucharzJacek FijuthPublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2020)
The dose-volume parameters of BMact serve as better predictors of ALCnadir% and PLTnadir% than BMtot.